The trials that maintained participants at therapeutic doses showed sustained weight loss
In India, the price differential between the off-patent and original brands may be small, given existing aggressive pricing, and so robust RWE studies could give a differentiating edge, especially for companies developing oral semaglutide where the existing market is less established
Eli Lilly manufactures a comparable medication, Mounjaro, reportedly associated with similar severe side effects, though containing different active ingredients
Every patient receives a personalized plan that considers metabolic health, lifestyle, lab results, and nutritional needs
We do not accept insurance claims at this time